1
|
Meda N, Tuaillon E, Kania D, Tiendrebeogo A, Pisoni A, Zida S, Bollore K, Medah I, Laureillard D, Moles JP, Nagot N, Nebie KY, Van de Perre P, Dujols P. Hepatitis B and C virus seroprevalence, Burkina Faso: a cross-sectional study. Bull World Health Organ 2018; 96:750-759. [PMID: 30455530 PMCID: PMC6239015 DOI: 10.2471/blt.18.208603] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2018] [Revised: 06/30/2018] [Accepted: 07/01/2018] [Indexed: 12/24/2022] Open
Abstract
Objective To estimate population-wide hepatitis B and C seroprevalence using dried blood spot samples acquired for human immunodeficiency virus (HIV) surveillance as part of the 2010–2011 Demographic and Health Survey in Burkina Faso. Methods We used the database acquired during the multistage, clustered, population-based survey, in which 15 377 participants completed questionnaires and provided dried blood spot samples for HIV testing. We extracted sociodemographic and geographic data including age, sex, ethnicity, education, wealth, marital status and region for each participant. We performed hepatitis B and C assays on 14 886 HIV-negative samples between March to October 2015, and calculated weighted percentages of hepatitis seroprevalence for each variable. Findings We estimated seroprevalence as 9.1% (95% confidence interval, CI: 8.5–9.7) for the hepatitis B surface antigen and 3.6% (95% CI: 3.3–3.8) for hepatitis C virus antibodies, classifying Burkina Faso as highly endemic for hepatitis B and low-intermediate for hepatitis C. The seroprevalence of hepatitis was higher in men than in women, and varied significantly for both with age, education, ethnicity and region. Extremely high HCV-Ab seroprevalence (13.2%; 95% CI: 10.6–15.7) was identified in the Sud-Ouest region, in particular within the youngest age group (15–20 years), indicating an ongoing epidemic. Conclusion Our population-representative hepatitis seroprevalence estimates in Burkina Faso advocate for the inclusion of hepatitis serological tests and risk factor questionnaire items in future surveys, the results of which are crucial for the development of appropriate health policies and infection control programmes.
Collapse
Affiliation(s)
- Nicolas Meda
- Ministère de la Santé, Ouagadougou, Burkina Faso
| | - Edouard Tuaillon
- Pathogenesis and Control of Chronic Infections, Université de Montpellier, U 1058, 60 rue de Navacelles Montpellier, 34394 cedex 5, France
| | | | - Adama Tiendrebeogo
- Institut National de la Statistique et de la Demographie, Ministère de l'Economie, des Finances et du Développement, Ouagadougou, Burkina Faso
| | - Amandine Pisoni
- Pathogenesis and Control of Chronic Infections, Centre Hospitalier Universitaire de Montpellier, Montpellier, France
| | | | - Karine Bollore
- Pathogenesis and Control of Chronic Infections, Centre Hospitalier Universitaire de Montpellier, Montpellier, France
| | - Isaïe Medah
- Ministère de la Santé, Ouagadougou, Burkina Faso
| | - Didier Laureillard
- Pathogenesis and Control of Chronic Infections, Centre Hospitalier Universitaire de Nîmes, Nîmes, France
| | - Jean Pierre Moles
- Pathogenesis and Control of Chronic Infections, Institut National de la Santé et de la Recherche Médicale, Montpellier, France
| | - Nicolas Nagot
- Pathogenesis and Control of Chronic Infections, Université de Montpellier, U 1058, 60 rue de Navacelles Montpellier, 34394 cedex 5, France
| | | | - Philippe Van de Perre
- Pathogenesis and Control of Chronic Infections, Université de Montpellier, U 1058, 60 rue de Navacelles Montpellier, 34394 cedex 5, France
| | - Pierre Dujols
- Pathogenesis and Control of Chronic Infections, Université de Montpellier, U 1058, 60 rue de Navacelles Montpellier, 34394 cedex 5, France
| |
Collapse
|